Trial Profile
Effect of Eszopiclone (Lunesta) on Sleep Disturbance and Pain in Cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2016
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Pain; Sleep disorders
- Focus Therapeutic Use
- 01 Dec 2011 Results published in Supportive Care in Cancer.
- 24 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2009 Primary endpoint 'Sleep-measures' has been met.